Biofrontera Inc.（BFRI）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · BFRI · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$41.70M	$37.30M	$34.07M	$28.67M	$24.10M
Cost of Revenue	$8.90M	$18.61M	$17.44M	$15.19M	$12.74M
Gross Profit	$32.80M	$18.70M	$16.63M	$13.49M	$11.36M
Gross Margin %(computed)	78.65%	50.12%	48.80%	47.04%	47.13%
Operating Expenses
R&D Expenses	$3.72M	$2.09M	$0.08M	$0.00M	$0.00M
G&A Expenses	$0.00M	$0.00M	$37.70M	$35.87M	$37.21M
Total Operating Expenses	$41.95M	$35.92M	$39.30M	$32.07M	$36.56M
Operating Income	($9.15M)	($17.21M)	($22.68M)	($18.58M)	($25.20M)
Operating Margin %(computed)	-21.94%	-46.14%	-66.56%	-64.80%	-104.57%
Interest Income	$0.00M	$0.03M	$0.13M	$0.17M	$0.02M
Interest Expense	$0.45M	$2.11M	$0.60M	$0.37M	$0.36M
Income Before Tax	($10.51M)	($17.74M)	($20.12M)	($0.61M)	($37.66M)
Income Tax Expense	$0.03M	$0.02M	$0.01M	$0.03M	$0.06M
Net Income	($10.54M)	($17.76M)	($20.13M)	($0.64M)	($37.71M)
Net Margin %(computed)	-25.26%	-47.61%	-59.09%	-2.23%	-156.49%
Per Share & EBITDA
EPS (Basic)	$-1.04	$-3.22	$-13.02	$-0.61	$-44.10
Wtd Avg Shares	10.17M	5.52M	1.55M	1.06M	0.86M
EBITDA	($8.28M)	($14.44M)	($18.45M)	$0.93M	($36.76M)
EBITDA Margin %(computed)	-19.85%	-38.71%	-54.16%	3.26%	-152.52%